| Glaxosmithkline Pharmaceuticals Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
|
|
|
|
|
|
|
|
| Year | High (₹) | Low (₹) | Close (₹) | P/E High | P/E Low | P/E Close | Mkt Cap (₹ In Cr) |
|---|---|---|---|---|---|---|---|
| Jun 2025 | 3,515.95 | 3,152.05 | 3,386.70 | 69.94 | 61.36 | 66.29 | 57,372.74 |
| May 2025 | 3,396.00 | 2,699.30 | 3,295.00 | 67.39 | 51.71 | 64.50 | 55,819.29 |
| Apr 2025 | 3,147.45 | 2,275.05 | 2,959.45 | 66.48 | 39.31 | 57.93 | 50,134.87 |
| Mar 2025 | 2,975.00 | 2,397.00 | 2,877.30 | 60.09 | 44.72 | 56.32 | 48,743.20 |
| Feb 2025 | 2,744.95 | 1,924.30 | 2,474.55 | 77.48 | 48.56 | 64.37 | 41,920.37 |
| Jan 2025 | 2,271.20 | 1,963.00 | 1,976.25 | 60.06 | 50.72 | 51.41 | 33,478.87 |
| Dec 2024 | 2,459.95 | 2,164.05 | 2,252.00 | 64.99 | 54.09 | 58.58 | 38,150.24 |
| Nov 2024 | 2,746.15 | 2,309.00 | 2,445.70 | 71.86 | 57.89 | 63.62 | 41,431.63 |
| Oct 2024 | 2,887.65 | 2,505.00 | 2,719.80 | 78.60 | 63.10 | 70.75 | 46,075.05 |
| Sep 2024 | 2,958.45 | 2,669.60 | 2,754.80 | 80.45 | 66.63 | 71.66 | 46,667.97 |